Exabis Library
Welcome to the e-CCO Library!
P441: Higher education, professional occupation and upper socio-economic status is associated with lower adherence to medications in patients with inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P441: Long-term CD treatment failure and dose modification rates with vedolizumab and other biologics: Results from a large prospective observational study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P441: Long-term immunogenicity of vedolizumab in ulcerative colitis and Crohn’s disease (GEMINI Programme)
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P441: Thalidomide induces clinical remission and mucosal healing in adults with active Crohn's disease: a prospective open-label study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P442 Long-term quality of life after surgery for perianal Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P442: Endoscopic resection of visible precancerous lesions in patients with colonic Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P442: Evaluation of safety and efficacy of laparoscopic surgery for ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P442: Incidence of pneumonia and other respiratory tract infections with vedolizumab treatment for inflammatory bowel disease: clinical trial experience
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P442: Real-world endoscopic and histologic outcomes are linked to ustekinumab exposure in Ulcerative Colitis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P442: Serum vedolizumab trough levels are associated with remission rate but not with extra-intestinal manifestations in IBD patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P442: Strictureplasty for Crohn’s disease of the small bowel in the biological era: long-term outcomes and risk factors for site specific recurrence
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P442: The additional value of cytapheresis therapy in patients with severe ulcerative colitis treated with oral tacrolimus
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P443 Magnetic resonance imaging after ligation of the intersphincteric fistula tract for high perianal fistulas in Crohn’s disease: a retrospective cohort study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P443: Clinical features, therapeutic requirements, and evolution of patients with Crohn's disease and upper digestive tract involvement (CROHNEX study)
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P443: Haemorrhoidal Artery Ligation – Recto-Anal Repair (HAL-RAR) with mucopexy for grade III hemorrhoids in IBD patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P443: National treatment strategy in inflammatory bowel diseases in Hungary: results from the National Health Insurance Fund Prescription Database
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P443: Risk of incident Cancer in Patients with Inflammatory Bowel Disease with Prior Breast Cancer: a Multicentre Cohort Study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P443: Systematic analysis of annual health resource utilisation and costs in hospitalised inflammatory bowel disease patients in Switzerland
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P443: Systematic review of internet decision making resources for patients considering surgery for ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P443: Trough concentration response in infliximab and adalimumab treated children with IBD following treatment adjustment: A pharmacokinetic model.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM